Moderna unsure of COVID-19 vaccine patent exclusivity

12-08-2020

Sarah Morgan

Moderna unsure of COVID-19 vaccine patent exclusivity

siam.pukkato / Shutterstock.com

US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine. 


Moderna, biotech, patent applications, COVID-19, COVID-19 vaccines, exclusivity, Operation Warp Speed, Donald Trump,

LSIPR